相关实验视频

Updated: Jan 18, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

潜在的反感性寡核酸向LINC00673在舌头状细胞癌的增殖和亡

Kadek Gede Putra Wibawa¹, Supriatno², Juni Handajani³

¹Master Study Program. Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Journal of Taibah University Medical Sciences

|January 16, 2026

概括

针对长非编码RNA 673 (LINC00673) 的反感疗法有效抑制了舌头癌细胞的增殖,并诱导了H357细胞的亡. 这种方法对治疗侵袭性人类舌头癌症有前途.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
在RNA治疗方面,RNA疗法.

背景情况:

在全球范围内,舌癌的发病率正在增加,通常与预后不佳有关.
长非编码RNA 673 (LINC00673) 的高表达与人类舌头癌的生存率降低和较大的瘤相关.
反意义疗法提供了一个有针对性的策略,通过RNAase-H1活性降解LINC00673.

研究的目的:

评估LINC00673反感性寡核酸在抑制增殖中的有效性.
评估LINC00673反感性寡核酸在诱导亡方面的潜力.
调查对人类舌头癌细胞的治疗潜力 (H357).

主要方法:

人类舌头癌症H357细胞被LINC00673反感,感觉和混控制寡核酸 (SCO) 感染.
细胞增殖被测量使用甲基提亚四测定.
通过阿克里丁-乙化物染色来评估亡.

主要成果:

与对照组相比,LINC00673反感性寡核酸显著降低了H357细胞的增殖.
反感性寡核酸治疗诱导了显著的亡,由明显的形态变化和光证明.
对照组 (感觉,SCO,仅传染,负) 显示主要是活性的细胞.

结论:

LINC00673反感性寡核酸对舌头癌细胞增殖具有显著的抑制作用.
这种治疗有效地诱导了人类舌头癌细胞的亡.
这项研究支持LINC00673反感性寡核酸作为舌头癌症的潜在治疗剂.

关键词:

这是一种反意义的寡核酸.细胞灭亡 (apoptosis) 是一种死亡的过程.这里是 LINC00673 的位置.长的非编码RNA是什么?核武器的扩散舌头状细胞癌瘤

更多相关视频

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on: January 9, 2020

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

Published on: June 2, 2016

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...